Immediate Impact
54 standout
Citing Papers
Liver diseases: epidemiology, causes, trends and predictions
2025 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Kadry Elsaeed being referenced
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience
2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kadry Elsaeed | 267 | 287 | 33 | 12 | 337 | |
| Kazutomo Suzuki | 127 | 133 | 39 | 16 | 331 | |
| B Lebkiri | 149 | 145 | 21 | 11 | 336 | |
| S. W. Schalm | 218 | 243 | 22 | 21 | 327 | |
| Walter H. Jacobs | 208 | 81 | 14 | 11 | 410 | |
| Cinzia Balestrieri | 184 | 173 | 32 | 16 | 370 | |
| R. D'Souza | 289 | 283 | 16 | 11 | 380 | |
| S Sushma | 193 | 263 | 41 | 8 | 355 | |
| Claudio Rodríguez-Ramos | 217 | 206 | 74 | 12 | 391 | |
| Érika Rabelo Forte de Siqueira | 230 | 142 | 15 | 11 | 350 | |
| Mitsuhiko Kawaguchi | 227 | 211 | 37 | 15 | 388 |
All Works
Login with ORCID to disown or claim papers
Loading papers...